Table 2.
Laboratory and ultrasound characteristics of the study population.
Parameters | Total (n=40) |
TG(<1.7) | TG(≥1.7) | p |
---|---|---|---|---|
n=18 | n=22 | |||
HbA1c (%) | 7.72 ± 0.27 | 7.88 ± 0.45 | 7.59 ± 0.37 | 0.67 |
TC (mmol/l) | 5.00 ± 0.36 | 4.59 ± 0.29 | 5.35 ± 0.60 | 0.32 |
TG (mmol/l) | 2.52 ± 0.29 | 1.37 ± 0.07 | 3.54 ± 0.42 | <0.01 |
HDL-C (mmol/l) | 1.13 ± 0.04 | 1.15± 0.06 | 1.11 ± 0.06 | 0.70 |
LDL-C (mmol/l) | 3.08 ± 0.14 | 2.95 ± 0.22 | 3.19 ± 0.17 | 0.24 |
CAP (dB/m) | 328.1 ± 8.74 | 299.2 ± 13.11 | 345.7 ± 9.20 | <0.01 |
LSM (kPa) | 10.44 ± 1.26 | 10.42 ± 2.21 | 10.45 ± 1.47 | 0.82 |
Data are presented as mean ± SEM; p values are based on t-test or Mann-Whitney test, and p < 0.05 was considered statistically significant; HbA1c, glycated hemoglobin; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; CAP, controlled attenuation parameter; LSM, liver stiffness measurement.